

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine metabolic process (GO:0006558) | 4.46947722 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.46947722 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.34070020 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.34070020 |
| 5 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 4.13569527 |
| 6 | regulation of cholesterol homeostasis (GO:2000188) | 3.98430802 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 3.94821832 |
| 8 | protein retention in ER lumen (GO:0006621) | 3.90940193 |
| 9 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.79079066 |
| 10 | positive regulation of histone deacetylation (GO:0031065) | 3.67023962 |
| 11 | regulation of early endosome to late endosome transport (GO:2000641) | 3.65516808 |
| 12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.61450837 |
| 13 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.60925434 |
| 14 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.50421615 |
| 15 | cell-cell junction maintenance (GO:0045217) | 3.50359750 |
| 16 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.42601851 |
| 17 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.39616839 |
| 18 | 2-oxoglutarate metabolic process (GO:0006103) | 3.37495913 |
| 19 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.35800768 |
| 20 | viral transcription (GO:0019083) | 3.34049186 |
| 21 | lysine catabolic process (GO:0006554) | 3.32191493 |
| 22 | lysine metabolic process (GO:0006553) | 3.32191493 |
| 23 | aromatic amino acid family catabolic process (GO:0009074) | 3.29248467 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.28825103 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 3.27659916 |
| 26 | activation of MAPKKK activity (GO:0000185) | 3.25419955 |
| 27 | semaphorin-plexin signaling pathway (GO:0071526) | 3.24590515 |
| 28 | protein localization to endosome (GO:0036010) | 3.23368771 |
| 29 | valine metabolic process (GO:0006573) | 3.21939583 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.21836083 |
| 31 | protein carboxylation (GO:0018214) | 3.21836083 |
| 32 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.19466639 |
| 33 | barbed-end actin filament capping (GO:0051016) | 3.15839868 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.14618088 |
| 35 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.13332369 |
| 36 | glutamate metabolic process (GO:0006536) | 3.12830609 |
| 37 | apoptotic process involved in morphogenesis (GO:0060561) | 3.11764081 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.10581858 |
| 39 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.05295538 |
| 40 | basement membrane organization (GO:0071711) | 3.02521690 |
| 41 | modulation by symbiont of host cellular process (GO:0044068) | 3.00117668 |
| 42 | regulation of extracellular matrix disassembly (GO:0010715) | 2.99566633 |
| 43 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.98563080 |
| 44 | stress fiber assembly (GO:0043149) | 2.98348392 |
| 45 | glyoxylate metabolic process (GO:0046487) | 2.97864838 |
| 46 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.97377079 |
| 47 | maternal placenta development (GO:0001893) | 2.97059050 |
| 48 | negative regulation of fatty acid transport (GO:2000192) | 2.95495810 |
| 49 | negative regulation of sterol transport (GO:0032372) | 2.95196067 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 2.95196067 |
| 51 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.93607075 |
| 52 | aspartate family amino acid catabolic process (GO:0009068) | 2.91904897 |
| 53 | tricarboxylic acid metabolic process (GO:0072350) | 2.91716738 |
| 54 | kynurenine metabolic process (GO:0070189) | 2.90451666 |
| 55 | urea cycle (GO:0000050) | 2.90282163 |
| 56 | urea metabolic process (GO:0019627) | 2.90282163 |
| 57 | cysteine metabolic process (GO:0006534) | 2.89663289 |
| 58 | adherens junction assembly (GO:0034333) | 2.88906488 |
| 59 | negative regulation of cell size (GO:0045792) | 2.87923382 |
| 60 | bile acid biosynthetic process (GO:0006699) | 2.87576541 |
| 61 | translational termination (GO:0006415) | 2.87459695 |
| 62 | cellular modified amino acid catabolic process (GO:0042219) | 2.87371260 |
| 63 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.83869420 |
| 64 | modulation by virus of host process (GO:0019054) | 2.83147862 |
| 65 | positive regulation of lipid catabolic process (GO:0050996) | 2.82878796 |
| 66 | negative regulation of fibrinolysis (GO:0051918) | 2.82666867 |
| 67 | Golgi transport vesicle coating (GO:0048200) | 2.82615608 |
| 68 | COPI coating of Golgi vesicle (GO:0048205) | 2.82615608 |
| 69 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.79895383 |
| 70 | ribosomal small subunit biogenesis (GO:0042274) | 2.77180969 |
| 71 | adhesion of symbiont to host (GO:0044406) | 2.75948736 |
| 72 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.75719203 |
| 73 | creatine metabolic process (GO:0006600) | 2.74839766 |
| 74 | focal adhesion assembly (GO:0048041) | 2.73455355 |
| 75 | cell-substrate adherens junction assembly (GO:0007045) | 2.73455355 |
| 76 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.73049530 |
| 77 | regulation of triglyceride metabolic process (GO:0090207) | 2.72791695 |
| 78 | protein-lipid complex assembly (GO:0065005) | 2.71774074 |
| 79 | positive regulation of fatty acid oxidation (GO:0046321) | 2.71700585 |
| 80 | 4-hydroxyproline metabolic process (GO:0019471) | 2.71639988 |
| 81 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.70050848 |
| 82 | regulation of fatty acid oxidation (GO:0046320) | 2.68239279 |
| 83 | complement activation, alternative pathway (GO:0006957) | 2.67434469 |
| 84 | endothelial cell chemotaxis (GO:0035767) | 2.65778094 |
| 85 | dicarboxylic acid catabolic process (GO:0043649) | 2.64912026 |
| 86 | regulation of triglyceride catabolic process (GO:0010896) | 2.64336924 |
| 87 | sodium ion export (GO:0071436) | 2.63792589 |
| 88 | ethanol oxidation (GO:0006069) | 2.63241921 |
| 89 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.63001324 |
| 90 | negative regulation of cell killing (GO:0031342) | 2.63001324 |
| 91 | negative regulation of lipid transport (GO:0032369) | 2.61289177 |
| 92 | positive regulation of extracellular matrix organization (GO:1903055) | 2.60727965 |
| 93 | virion attachment to host cell (GO:0019062) | 2.58155364 |
| 94 | adhesion of symbiont to host cell (GO:0044650) | 2.58155364 |
| 95 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.58140869 |
| 96 | alpha-amino acid catabolic process (GO:1901606) | 2.57748305 |
| 97 | nitrogen cycle metabolic process (GO:0071941) | 2.57742601 |
| 98 | response to laminar fluid shear stress (GO:0034616) | 2.57590982 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 2.57111432 |
| 100 | atrioventricular valve morphogenesis (GO:0003181) | 2.56145276 |
| 101 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.55604422 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.55604422 |
| 103 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.55596504 |
| 104 | positive regulation of protein dephosphorylation (GO:0035307) | 2.55541301 |
| 105 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.54787254 |
| 106 | skin morphogenesis (GO:0043589) | 2.53917852 |
| 107 | serine family amino acid catabolic process (GO:0009071) | 2.53609949 |
| 108 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.53424419 |
| 109 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.52892227 |
| 110 | embryo implantation (GO:0007566) | 2.52583432 |
| 111 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.52124826 |
| 112 | high-density lipoprotein particle remodeling (GO:0034375) | 2.52043191 |
| 113 | indole-containing compound catabolic process (GO:0042436) | 2.50852619 |
| 114 | indolalkylamine catabolic process (GO:0046218) | 2.50852619 |
| 115 | tryptophan catabolic process (GO:0006569) | 2.50852619 |
| 116 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.49787632 |
| 117 | modulation by virus of host morphology or physiology (GO:0019048) | 2.49319408 |
| 118 | regulation of ARF protein signal transduction (GO:0032012) | 2.49272448 |
| 119 | cellular amino acid catabolic process (GO:0009063) | 2.48653175 |
| 120 | regulation of extracellular matrix organization (GO:1903053) | 2.48610946 |
| 121 | positive thymic T cell selection (GO:0045059) | 2.48499909 |
| 122 | amino-acid betaine metabolic process (GO:0006577) | 2.47882102 |
| 123 | regulation of protein activation cascade (GO:2000257) | 2.47792545 |
| 124 | viral life cycle (GO:0019058) | 2.46128152 |
| 125 | positive regulation of glycogen metabolic process (GO:0070875) | 2.45920802 |
| 126 | reverse cholesterol transport (GO:0043691) | 2.45906064 |
| 127 | plasma lipoprotein particle assembly (GO:0034377) | 2.45898262 |
| 128 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.45733333 |
| 129 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.45733333 |
| 130 | regulation of cholesterol storage (GO:0010885) | 2.44773437 |
| 131 | mannose metabolic process (GO:0006013) | 2.43017063 |
| 132 | bile acid metabolic process (GO:0008206) | 2.42804153 |
| 133 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.42783221 |
| 134 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.42639770 |
| 135 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.42505621 |
| 136 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.42420802 |
| 137 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.42056366 |
| 138 | activation of Rac GTPase activity (GO:0032863) | 2.41912697 |
| 139 | UV protection (GO:0009650) | 2.41224968 |
| 140 | retrograde transport, endosome to Golgi (GO:0042147) | 2.40852255 |
| 141 | short-chain fatty acid metabolic process (GO:0046459) | 2.40413399 |
| 142 | regulation of cholesterol metabolic process (GO:0090181) | 2.40217404 |
| 143 | regulation of lipid catabolic process (GO:0050994) | 2.39982240 |
| 144 | translational elongation (GO:0006414) | 2.39514375 |
| 145 | convergent extension (GO:0060026) | 2.39276755 |
| 146 | pentose-phosphate shunt (GO:0006098) | 2.39243876 |
| 147 | fatty acid beta-oxidation (GO:0006635) | 2.37954602 |
| 148 | regulation of ARF GTPase activity (GO:0032312) | 2.37911055 |
| 149 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.36354729 |
| 150 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.35888851 |
| 151 | regulation of fibrinolysis (GO:0051917) | 2.34529448 |
| 152 | cortical actin cytoskeleton organization (GO:0030866) | 2.34454417 |
| 153 | activation of JUN kinase activity (GO:0007257) | 2.34407443 |
| 154 | regulation of complement activation (GO:0030449) | 2.34333186 |
| 155 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.34117589 |
| 156 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.33109009 |
| 157 | positive regulation of protein deacetylation (GO:0090312) | 2.32179398 |
| 158 | response to mercury ion (GO:0046689) | 2.31954904 |
| 159 | acylglycerol catabolic process (GO:0046464) | 2.31696565 |
| 160 | apoptotic process involved in development (GO:1902742) | 2.31370157 |
| 161 | protein targeting to plasma membrane (GO:0072661) | 2.29489199 |
| 162 | cellular protein complex disassembly (GO:0043624) | 2.29165266 |
| 163 | cell junction maintenance (GO:0034331) | 2.28908943 |
| 164 | positive regulation of nuclease activity (GO:0032075) | 2.27211325 |
| 165 | cochlea morphogenesis (GO:0090103) | 2.26896258 |
| 166 | cell-substrate junction assembly (GO:0007044) | 2.26425013 |
| 167 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.25332270 |
| 168 | pinocytosis (GO:0006907) | 2.25314021 |
| 169 | regulation of establishment of planar polarity (GO:0090175) | 2.24551428 |
| 170 | dopamine receptor signaling pathway (GO:0007212) | 2.24307622 |
| 171 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.23424914 |
| 172 | protein complex disassembly (GO:0043241) | 2.21940518 |
| 173 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.21758244 |
| 174 | glial cell migration (GO:0008347) | 2.21723149 |
| 175 | regulation of monocyte differentiation (GO:0045655) | 2.21608323 |
| 176 | negative regulation of catenin import into nucleus (GO:0035414) | 2.19055778 |
| 177 | cellular response to virus (GO:0098586) | 2.18883130 |
| 178 | low-density lipoprotein particle clearance (GO:0034383) | 2.18122211 |
| 179 | response to muramyl dipeptide (GO:0032495) | 2.18015578 |
| 180 | response to parathyroid hormone (GO:0071107) | 2.17139696 |
| 181 | cell migration in hindbrain (GO:0021535) | 2.16970896 |
| 182 | cell volume homeostasis (GO:0006884) | 2.16106839 |
| 183 | glucose catabolic process (GO:0006007) | 2.15578855 |
| 184 | actin filament bundle assembly (GO:0051017) | 2.14086085 |
| 185 | actin filament bundle organization (GO:0061572) | 2.14086085 |
| 186 | glycosphingolipid catabolic process (GO:0046479) | 2.13284171 |
| 187 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.12937437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.53095959 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.39371821 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.24574056 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.10184947 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.90242377 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.86092088 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.67419405 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.66903084 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.65280064 |
| 10 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.55400638 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.53588442 |
| 12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.45975849 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35818991 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.30828084 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.20645494 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.17755314 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.16707258 |
| 18 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.15948295 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.09776497 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.97143348 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.96946949 |
| 22 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.89808353 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87044194 |
| 24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.84136358 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79245648 |
| 26 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77978541 |
| 27 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.76727296 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.74667117 |
| 29 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.70080923 |
| 30 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.69050811 |
| 31 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.68053157 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.67975254 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66357536 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.63768918 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58846386 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58025754 |
| 37 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.57165711 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54932934 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.49142651 |
| 40 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.48760362 |
| 41 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48380294 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48210479 |
| 43 | P68_20966046_ChIP-Seq_HELA_Human | 1.48157369 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47429232 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46192326 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.45356119 |
| 47 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.44157254 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.43718885 |
| 49 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.42701091 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.39293763 |
| 51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38213873 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36839156 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36804042 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32871420 |
| 55 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32779925 |
| 56 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.31485007 |
| 57 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31158878 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29706564 |
| 59 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26740831 |
| 60 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.26337379 |
| 61 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25448865 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.24556101 |
| 63 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24535937 |
| 64 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24076178 |
| 65 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.23965468 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23110149 |
| 67 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22742118 |
| 68 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.21413494 |
| 69 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.20969631 |
| 70 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20441571 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20254131 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19107811 |
| 73 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.17560991 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17371675 |
| 75 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17294104 |
| 76 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15275344 |
| 77 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15100625 |
| 78 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14936165 |
| 79 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14463873 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14029501 |
| 81 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13520359 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12699552 |
| 83 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.12531144 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12312607 |
| 85 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.11040777 |
| 86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11014290 |
| 87 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.10719025 |
| 88 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10233363 |
| 89 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09754293 |
| 90 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.08981104 |
| 91 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07600497 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06476476 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06258675 |
| 94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05721020 |
| 95 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05613242 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05430394 |
| 97 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05035162 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05035162 |
| 99 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04914782 |
| 100 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.04127132 |
| 101 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03949295 |
| 102 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.03623930 |
| 103 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03379645 |
| 104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03180499 |
| 105 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02586497 |
| 106 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02138972 |
| 107 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01766972 |
| 108 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.01306797 |
| 109 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.00481953 |
| 110 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.00278316 |
| 111 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.00133566 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00068080 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99652881 |
| 114 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98913605 |
| 115 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98392048 |
| 116 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.98325640 |
| 117 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98297948 |
| 118 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.97626960 |
| 119 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96960984 |
| 120 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96817869 |
| 121 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96801699 |
| 122 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96322321 |
| 123 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.95713775 |
| 124 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94407509 |
| 125 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.94074838 |
| 126 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92757426 |
| 127 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.91634127 |
| 128 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.90740908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.61241432 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.49479124 |
| 3 | MP0005365_abnormal_bile_salt | 3.80408928 |
| 4 | MP0009840_abnormal_foam_cell | 3.61028571 |
| 5 | MP0008961_abnormal_basal_metabolism | 3.22383932 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.99736995 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.81417099 |
| 8 | MP0003303_peritoneal_inflammation | 2.78720898 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.73903213 |
| 10 | MP0003252_abnormal_bile_duct | 2.68248437 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.59825929 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.46711925 |
| 13 | MP0005451_abnormal_body_composition | 2.46692191 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.39775343 |
| 15 | MP0004130_abnormal_muscle_cell | 2.38093783 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.32436288 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.25896083 |
| 18 | MP0001348_abnormal_lacrimal_gland | 2.25093393 |
| 19 | MP0005083_abnormal_biliary_tract | 2.15584319 |
| 20 | MP0004185_abnormal_adipocyte_glucose | 2.09792527 |
| 21 | MP0004510_myositis | 2.09008511 |
| 22 | MP0002249_abnormal_larynx_morphology | 2.05968105 |
| 23 | MP0000678_abnormal_parathyroid_gland | 1.96680966 |
| 24 | MP0004859_abnormal_synaptic_plasticity | 1.88443324 |
| 25 | MP0005503_abnormal_tendon_morphology | 1.86296928 |
| 26 | MP0000685_abnormal_immune_system | 1.84895721 |
| 27 | MP0003329_amyloid_beta_deposits | 1.80598392 |
| 28 | MP0003436_decreased_susceptibility_to | 1.79192878 |
| 29 | MP0000609_abnormal_liver_physiology | 1.76055463 |
| 30 | MP0005332_abnormal_amino_acid | 1.73972512 |
| 31 | MP0005409_darkened_coat_color | 1.73301270 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.70143218 |
| 33 | MP0006054_spinal_hemorrhage | 1.69597918 |
| 34 | MP0010030_abnormal_orbit_morphology | 1.69548366 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.67864188 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.63391004 |
| 37 | MP0008260_abnormal_autophagy | 1.62429142 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.59344680 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.56128585 |
| 40 | MP0009278_abnormal_bone_marrow | 1.54169872 |
| 41 | MP0005375_adipose_tissue_phenotype | 1.53850597 |
| 42 | MP0003123_paternal_imprinting | 1.50988243 |
| 43 | MP0000604_amyloidosis | 1.50951272 |
| 44 | MP0000747_muscle_weakness | 1.48302334 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40621160 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.38680574 |
| 47 | MP0000003_abnormal_adipose_tissue | 1.38303198 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.37874065 |
| 49 | MP0001666_abnormal_nutrient_absorption | 1.37077890 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.36701905 |
| 51 | MP0003075_altered_response_to | 1.34413163 |
| 52 | MP0003634_abnormal_glial_cell | 1.32370845 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.32035274 |
| 54 | MP0000751_myopathy | 1.31793228 |
| 55 | MP0009384_cardiac_valve_regurgitation | 1.31196869 |
| 56 | MP0002822_catalepsy | 1.28871386 |
| 57 | MP0003879_abnormal_hair_cell | 1.21369761 |
| 58 | MP0005508_abnormal_skeleton_morphology | 1.19337614 |
| 59 | MP0003283_abnormal_digestive_organ | 1.17975197 |
| 60 | MP0005023_abnormal_wound_healing | 1.16966433 |
| 61 | MP0004087_abnormal_muscle_fiber | 1.15463218 |
| 62 | MP0004858_abnormal_nervous_system | 1.15085150 |
| 63 | MP0000858_altered_metastatic_potential | 1.14409311 |
| 64 | MP0009780_abnormal_chondrocyte_physiolo | 1.12821521 |
| 65 | MP0000681_abnormal_thyroid_gland | 1.12661057 |
| 66 | MP0003942_abnormal_urinary_system | 1.10717087 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.10262484 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.08105478 |
| 69 | MP0000733_abnormal_muscle_development | 1.03341904 |
| 70 | MP0003195_calcinosis | 1.02398463 |
| 71 | MP0002896_abnormal_bone_mineralization | 1.00834510 |
| 72 | MP0000767_abnormal_smooth_muscle | 1.00154585 |
| 73 | MP0008874_decreased_physiological_sensi | 0.98096336 |
| 74 | MP0002269_muscular_atrophy | 0.97379338 |
| 75 | MP0002078_abnormal_glucose_homeostasis | 0.97237480 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 0.97160972 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 0.96707216 |
| 78 | MP0005390_skeleton_phenotype | 0.96687485 |
| 79 | MP0001851_eye_inflammation | 0.96611675 |
| 80 | MP0008569_lethality_at_weaning | 0.95461669 |
| 81 | MP0000343_altered_response_to | 0.94928298 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 0.93451886 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.92966974 |
| 84 | MP0002254_reproductive_system_inflammat | 0.92771901 |
| 85 | MP0003122_maternal_imprinting | 0.92214935 |
| 86 | MP0005275_abnormal_skin_tensile | 0.91928216 |
| 87 | MP0001958_emphysema | 0.91576918 |
| 88 | MP0009053_abnormal_anal_canal | 0.91501410 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.90545921 |
| 90 | MP0002933_joint_inflammation | 0.90041622 |
| 91 | MP0003045_fibrosis | 0.89854766 |
| 92 | MP0002060_abnormal_skin_morphology | 0.88511356 |
| 93 | MP0010630_abnormal_cardiac_muscle | 0.88317396 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.87832913 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.87478802 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.86844532 |
| 97 | MP0001944_abnormal_pancreas_morphology | 0.85531175 |
| 98 | MP0000759_abnormal_skeletal_muscle | 0.85468305 |
| 99 | MP0005423_abnormal_somatic_nervous | 0.84660232 |
| 100 | MP0000920_abnormal_myelination | 0.84322130 |
| 101 | MP0000598_abnormal_liver_morphology | 0.83779394 |
| 102 | MP0003279_aneurysm | 0.83774901 |
| 103 | MP0005166_decreased_susceptibility_to | 0.83405947 |
| 104 | MP0000534_abnormal_ureter_morphology | 0.82162357 |
| 105 | MP0000566_synostosis | 0.82147619 |
| 106 | MP0003633_abnormal_nervous_system | 0.81009486 |
| 107 | MP0003690_abnormal_glial_cell | 0.80052876 |
| 108 | MP0005330_cardiomyopathy | 0.79885756 |
| 109 | MP0005387_immune_system_phenotype | 0.79681124 |
| 110 | MP0001790_abnormal_immune_system | 0.79681124 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.79633347 |
| 112 | MP0002089_abnormal_postnatal_growth/wei | 0.78667588 |
| 113 | MP0000750_abnormal_muscle_regeneration | 0.77986552 |
| 114 | MP0002113_abnormal_skeleton_development | 0.77246195 |
| 115 | MP0004947_skin_inflammation | 0.76366736 |
| 116 | MP0000537_abnormal_urethra_morphology | 0.74778912 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.74741922 |
| 118 | MP0002932_abnormal_joint_morphology | 0.74411465 |
| 119 | MP0001849_ear_inflammation | 0.74357557 |
| 120 | MP0002971_abnormal_brown_adipose | 0.73972995 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.73867332 |
| 122 | MP0005076_abnormal_cell_differentiation | 0.73536934 |
| 123 | MP0000013_abnormal_adipose_tissue | 0.73474812 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.72544715 |
| 125 | MP0002116_abnormal_craniofacial_bone | 0.71241427 |
| 126 | MP0005670_abnormal_white_adipose | 0.70797041 |
| 127 | MP0009642_abnormal_blood_homeostasis | 0.70382563 |
| 128 | MP0000749_muscle_degeneration | 0.70177009 |
| 129 | MP0004885_abnormal_endolymph | 0.69864816 |
| 130 | MP0005167_abnormal_blood-brain_barrier | 0.69467556 |
| 131 | MP0005334_abnormal_fat_pad | 0.69259692 |
| 132 | MP0001545_abnormal_hematopoietic_system | 0.68557996 |
| 133 | MP0005397_hematopoietic_system_phenotyp | 0.68557996 |
| 134 | MP0001502_abnormal_circadian_rhythm | 0.68017145 |
| 135 | MP0001853_heart_inflammation | 0.68008362 |
| 136 | MP0010234_abnormal_vibrissa_follicle | 0.67745152 |
| 137 | MP0003011_delayed_dark_adaptation | 0.67569170 |
| 138 | MP0008469_abnormal_protein_level | 0.67111677 |
| 139 | MP0002796_impaired_skin_barrier | 0.66218477 |
| 140 | MP0003091_abnormal_cell_migration | 0.64307401 |
| 141 | MP0009115_abnormal_fat_cell | 0.63414508 |
| 142 | MP0004233_abnormal_muscle_weight | 0.63239884 |
| 143 | MP0005501_abnormal_skin_physiology | 0.63125528 |
| 144 | MP0001542_abnormal_bone_strength | 0.61704264 |
| 145 | MP0001873_stomach_inflammation | 0.61596387 |
| 146 | MP0002970_abnormal_white_adipose | 0.61129494 |
| 147 | MP0003115_abnormal_respiratory_system | 0.60646143 |
| 148 | MP0001756_abnormal_urination | 0.60443587 |
| 149 | MP0001270_distended_abdomen | 0.60431395 |
| 150 | MP0002108_abnormal_muscle_morphology | 0.60316042 |
| 151 | MP0008438_abnormal_cutaneous_collagen | 0.58366747 |
| 152 | MP0003866_abnormal_defecation | 0.57193874 |
| 153 | MP0005636_abnormal_mineral_homeostasis | 0.56836047 |
| 154 | MP0002419_abnormal_innate_immunity | 0.56502404 |
| 155 | MP0003948_abnormal_gas_homeostasis | 0.56364160 |
| 156 | MP0002092_abnormal_eye_morphology | 0.56271628 |
| 157 | MP0005535_abnormal_body_temperature | 0.55311873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.02062691 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.01143515 |
| 3 | Xanthomatosis (HP:0000991) | 3.58307566 |
| 4 | Obstructive sleep apnea (HP:0002870) | 3.56024418 |
| 5 | Ketosis (HP:0001946) | 3.42182794 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 3.27995885 |
| 7 | Hyperacusis (HP:0010780) | 3.09693716 |
| 8 | Cerebral aneurysm (HP:0004944) | 3.08194409 |
| 9 | Abnormality of the Achilles tendon (HP:0005109) | 3.00401410 |
| 10 | Cervical subluxation (HP:0003308) | 2.93577030 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 2.89977272 |
| 12 | Ketoacidosis (HP:0001993) | 2.88113178 |
| 13 | Vertebral compression fractures (HP:0002953) | 2.86376623 |
| 14 | Thin bony cortex (HP:0002753) | 2.79753830 |
| 15 | Achilles tendon contracture (HP:0001771) | 2.79004746 |
| 16 | Mitral regurgitation (HP:0001653) | 2.73003552 |
| 17 | Complement deficiency (HP:0004431) | 2.69207313 |
| 18 | Insomnia (HP:0100785) | 2.63158974 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.59116693 |
| 20 | Nuclear cataract (HP:0100018) | 2.56576853 |
| 21 | Turricephaly (HP:0000262) | 2.55469317 |
| 22 | Broad face (HP:0000283) | 2.54969027 |
| 23 | Striae distensae (HP:0001065) | 2.54766234 |
| 24 | Myocardial infarction (HP:0001658) | 2.53101729 |
| 25 | Hyperammonemia (HP:0001987) | 2.52756602 |
| 26 | Abnormality of the nasal mucosa (HP:0000433) | 2.47381934 |
| 27 | Exercise-induced myalgia (HP:0003738) | 2.44404673 |
| 28 | Polycythemia (HP:0001901) | 2.39984405 |
| 29 | Fragile skin (HP:0001030) | 2.35691308 |
| 30 | Hypoglycemic coma (HP:0001325) | 2.34275117 |
| 31 | Broad metatarsal (HP:0001783) | 2.33921046 |
| 32 | Shallow orbits (HP:0000586) | 2.33798492 |
| 33 | Late onset (HP:0003584) | 2.30063185 |
| 34 | Ulnar bowing (HP:0003031) | 2.28317790 |
| 35 | Hemiplegia (HP:0002301) | 2.27650143 |
| 36 | Nasal polyposis (HP:0100582) | 2.27391921 |
| 37 | Abnormality of the common coagulation pathway (HP:0010990) | 2.27288876 |
| 38 | Abnormality of complement system (HP:0005339) | 2.26720711 |
| 39 | Biconcave vertebral bodies (HP:0004586) | 2.26409576 |
| 40 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.26187433 |
| 41 | Atelectasis (HP:0100750) | 2.25822611 |
| 42 | Hyperglycinuria (HP:0003108) | 2.24567875 |
| 43 | Hypercholesterolemia (HP:0003124) | 2.24393499 |
| 44 | Joint stiffness (HP:0001387) | 2.23480613 |
| 45 | Hyperparathyroidism (HP:0000843) | 2.22524024 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 2.21215048 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21215048 |
| 48 | Abnormality of the thoracic spine (HP:0100711) | 2.20809607 |
| 49 | Distal upper limb amyotrophy (HP:0007149) | 2.19443705 |
| 50 | Upper limb amyotrophy (HP:0009129) | 2.19443705 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.18982371 |
| 52 | Neonatal onset (HP:0003623) | 2.18966747 |
| 53 | Genu recurvatum (HP:0002816) | 2.17981919 |
| 54 | Blue sclerae (HP:0000592) | 2.14913509 |
| 55 | Distal lower limb amyotrophy (HP:0008944) | 2.13719485 |
| 56 | Spinal rigidity (HP:0003306) | 2.11777478 |
| 57 | Hyperglycinemia (HP:0002154) | 2.11651993 |
| 58 | Supranuclear gaze palsy (HP:0000605) | 2.10862210 |
| 59 | Prolonged partial thromboplastin time (HP:0003645) | 2.10409809 |
| 60 | Short nail (HP:0001799) | 2.10396473 |
| 61 | Hypobetalipoproteinemia (HP:0003563) | 2.10141571 |
| 62 | Increased connective tissue (HP:0009025) | 2.07868409 |
| 63 | Elfin facies (HP:0004428) | 2.07726566 |
| 64 | J-shaped sella turcica (HP:0002680) | 2.07448840 |
| 65 | Gout (HP:0001997) | 2.06903701 |
| 66 | Thoracic kyphosis (HP:0002942) | 2.05704535 |
| 67 | Renovascular hypertension (HP:0100817) | 2.03875805 |
| 68 | Hyperthyroidism (HP:0000836) | 2.03700367 |
| 69 | Flat acetabular roof (HP:0003180) | 2.02734011 |
| 70 | Hemorrhage of the eye (HP:0011885) | 2.02002286 |
| 71 | Aneurysm (HP:0002617) | 2.01044521 |
| 72 | Round ear (HP:0100830) | 2.00265223 |
| 73 | Overriding aorta (HP:0002623) | 1.99856383 |
| 74 | Long palpebral fissure (HP:0000637) | 1.99574894 |
| 75 | Distal lower limb muscle weakness (HP:0009053) | 1.99442088 |
| 76 | Status epilepticus (HP:0002133) | 1.98997972 |
| 77 | Abnormality of dentin (HP:0010299) | 1.98789253 |
| 78 | Disproportionate tall stature (HP:0001519) | 1.97782239 |
| 79 | Mitral valve prolapse (HP:0001634) | 1.96323754 |
| 80 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.95688533 |
| 81 | Joint hemorrhage (HP:0005261) | 1.94694805 |
| 82 | Neurofibrillary tangles (HP:0002185) | 1.93994676 |
| 83 | Colitis (HP:0002583) | 1.93912546 |
| 84 | Bronchomalacia (HP:0002780) | 1.92882315 |
| 85 | Myoglobinuria (HP:0002913) | 1.92517953 |
| 86 | Lymphangioma (HP:0100764) | 1.92333981 |
| 87 | Hypoalphalipoproteinemia (HP:0003233) | 1.91862441 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91592221 |
| 89 | Mucopolysacchariduria (HP:0008155) | 1.91592221 |
| 90 | Mitral stenosis (HP:0001718) | 1.90612236 |
| 91 | Pointed chin (HP:0000307) | 1.90507170 |
| 92 | Arnold-Chiari malformation (HP:0002308) | 1.89588090 |
| 93 | Protrusio acetabuli (HP:0003179) | 1.88807190 |
| 94 | Cerebral inclusion bodies (HP:0100314) | 1.88753100 |
| 95 | Renal duplication (HP:0000075) | 1.88448426 |
| 96 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.87666422 |
| 97 | Emphysema (HP:0002097) | 1.87125348 |
| 98 | Annular pancreas (HP:0001734) | 1.87077272 |
| 99 | Dysmetric saccades (HP:0000641) | 1.86905251 |
| 100 | Back pain (HP:0003418) | 1.86529022 |
| 101 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.86078134 |
| 102 | Dysostosis multiplex (HP:0000943) | 1.85756557 |
| 103 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85593365 |
| 104 | Polygenic inheritance (HP:0010982) | 1.85007862 |
| 105 | Axonal loss (HP:0003447) | 1.84586642 |
| 106 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84276179 |
| 107 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84276179 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84276179 |
| 109 | Asymmetry of the thorax (HP:0001555) | 1.83271338 |
| 110 | Cupped ribs (HP:0000887) | 1.82354834 |
| 111 | Increased variability in muscle fiber diameter (HP:0003557) | 1.82201937 |
| 112 | Hand muscle atrophy (HP:0009130) | 1.81076708 |
| 113 | Hypolipoproteinemia (HP:0010981) | 1.80902755 |
| 114 | Abnormality of glycolipid metabolism (HP:0010969) | 1.80813036 |
| 115 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.80813036 |
| 116 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.80813036 |
| 117 | Gastrointestinal inflammation (HP:0004386) | 1.80792471 |
| 118 | Stridor (HP:0010307) | 1.80774979 |
| 119 | Reticulocytosis (HP:0001923) | 1.80741714 |
| 120 | Metaphyseal cupping (HP:0003021) | 1.80690316 |
| 121 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.80456974 |
| 122 | Death in childhood (HP:0003819) | 1.79358211 |
| 123 | Esophageal varix (HP:0002040) | 1.78812320 |
| 124 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.78811025 |
| 125 | Abnormal platelet function (HP:0011869) | 1.77801517 |
| 126 | Impaired platelet aggregation (HP:0003540) | 1.77801517 |
| 127 | Neoplasm of the heart (HP:0100544) | 1.76738706 |
| 128 | Broad distal phalanx of finger (HP:0009836) | 1.76582473 |
| 129 | Depression (HP:0000716) | 1.76023849 |
| 130 | Inflammation of the large intestine (HP:0002037) | 1.74404338 |
| 131 | Long toe (HP:0010511) | 1.73763305 |
| 132 | Abnormality of the lower motor neuron (HP:0002366) | 1.73414576 |
| 133 | Premature rupture of membranes (HP:0001788) | 1.73063596 |
| 134 | Vascular tortuosity (HP:0004948) | 1.73054206 |
| 135 | Atrophic scars (HP:0001075) | 1.72318165 |
| 136 | Asymmetric septal hypertrophy (HP:0001670) | 1.72011609 |
| 137 | Spinal cord compression (HP:0002176) | 1.71791345 |
| 138 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71775400 |
| 139 | Patellar dislocation (HP:0002999) | 1.71338929 |
| 140 | Neuronal loss in central nervous system (HP:0002529) | 1.70613242 |
| 141 | Dilatation of the ascending aorta (HP:0005111) | 1.70396211 |
| 142 | Hyporeflexia of lower limbs (HP:0002600) | 1.70131295 |
| 143 | Congenital glaucoma (HP:0001087) | 1.69579535 |
| 144 | Rapidly progressive (HP:0003678) | 1.69506267 |
| 145 | Spastic diplegia (HP:0001264) | 1.68260686 |
| 146 | Sudden death (HP:0001699) | 1.67618541 |
| 147 | Wormian bones (HP:0002645) | 1.67466728 |
| 148 | Hypertensive crisis (HP:0100735) | 1.67146376 |
| 149 | Hyperextensible skin (HP:0000974) | 1.66997180 |
| 150 | Cellulitis (HP:0100658) | 1.66510631 |
| 151 | Limb-girdle muscle atrophy (HP:0003797) | 1.66469131 |
| 152 | Papilloma (HP:0012740) | 1.66263741 |
| 153 | Verrucae (HP:0200043) | 1.66263741 |
| 154 | Bladder diverticulum (HP:0000015) | 1.66126636 |
| 155 | Myopathic facies (HP:0002058) | 1.65947628 |
| 156 | Truncus arteriosus (HP:0001660) | 1.65358897 |
| 157 | Neonatal short-limb short stature (HP:0008921) | 1.65164829 |
| 158 | Venous abnormality (HP:0002624) | 1.64928410 |
| 159 | Generalized hyperpigmentation (HP:0007440) | 1.64196792 |
| 160 | Premature skin wrinkling (HP:0100678) | 1.63164966 |
| 161 | Abnormal ossification of hand bones (HP:0005921) | 1.63104443 |
| 162 | Thin ribs (HP:0000883) | 1.63088850 |
| 163 | Ankle contracture (HP:0006466) | 1.62851265 |
| 164 | Joint laxity (HP:0001388) | 1.62590681 |
| 165 | Stroke (HP:0001297) | 1.61067729 |
| 166 | Delayed CNS myelination (HP:0002188) | 1.59257930 |
| 167 | Retinal atrophy (HP:0001105) | 1.58634668 |
| 168 | Hypercortisolism (HP:0001578) | 1.58327120 |
| 169 | Amyloidosis (HP:0011034) | 1.57890786 |
| 170 | Aortic aneurysm (HP:0004942) | 1.57521867 |
| 171 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.57052591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.19308616 |
| 2 | ERN1 | 3.40913121 |
| 3 | PRPF4B | 3.24111656 |
| 4 | SIK1 | 3.18701962 |
| 5 | MAP3K10 | 3.03239546 |
| 6 | PKN2 | 2.96879425 |
| 7 | SMG1 | 2.59184158 |
| 8 | FGFR4 | 2.35242969 |
| 9 | IRAK3 | 2.33719812 |
| 10 | EEF2K | 2.33293263 |
| 11 | PTK6 | 2.07692934 |
| 12 | BCKDK | 2.01052523 |
| 13 | MAP4K1 | 1.75813778 |
| 14 | ICK | 1.67767492 |
| 15 | MAP3K7 | 1.65371149 |
| 16 | MAPK15 | 1.54378703 |
| 17 | EPHB1 | 1.54226189 |
| 18 | NME2 | 1.54208930 |
| 19 | TAOK1 | 1.51802392 |
| 20 | PRKD3 | 1.51745583 |
| 21 | PRKD2 | 1.49270579 |
| 22 | TESK1 | 1.42399659 |
| 23 | PRKCH | 1.42390449 |
| 24 | TAOK2 | 1.42257701 |
| 25 | TTN | 1.37798259 |
| 26 | SIK2 | 1.35771405 |
| 27 | DDR2 | 1.31927393 |
| 28 | CAMK1G | 1.29840298 |
| 29 | LRRK2 | 1.28778964 |
| 30 | TBK1 | 1.27715481 |
| 31 | PDGFRA | 1.26165962 |
| 32 | ARAF | 1.25541187 |
| 33 | CDK12 | 1.21746022 |
| 34 | MARK2 | 1.21534662 |
| 35 | LMTK2 | 1.19081219 |
| 36 | DMPK | 1.15916891 |
| 37 | DAPK2 | 1.15513978 |
| 38 | EPHA2 | 1.13145286 |
| 39 | TGFBR2 | 1.10669610 |
| 40 | KIT | 1.08819216 |
| 41 | RIPK1 | 1.08278643 |
| 42 | RIPK4 | 1.07727791 |
| 43 | TYK2 | 1.04658426 |
| 44 | LATS2 | 1.04632660 |
| 45 | TLK1 | 1.02487469 |
| 46 | TAOK3 | 1.01583253 |
| 47 | JAK3 | 0.99220879 |
| 48 | HIPK2 | 0.97230723 |
| 49 | PRKD1 | 0.94941007 |
| 50 | NTRK2 | 0.92730903 |
| 51 | BTK | 0.90804388 |
| 52 | MAP3K11 | 0.89297784 |
| 53 | BMX | 0.87612011 |
| 54 | MAP2K3 | 0.86888405 |
| 55 | PHKG1 | 0.86361134 |
| 56 | PHKG2 | 0.86361134 |
| 57 | FLT3 | 0.86301960 |
| 58 | JAK2 | 0.86056425 |
| 59 | MAP3K6 | 0.85360078 |
| 60 | MAP3K1 | 0.84671165 |
| 61 | CAMKK1 | 0.84636131 |
| 62 | RPS6KC1 | 0.84072006 |
| 63 | RPS6KL1 | 0.84072006 |
| 64 | JAK1 | 0.83208646 |
| 65 | DYRK1B | 0.82066061 |
| 66 | RET | 0.81972500 |
| 67 | PIM2 | 0.80995701 |
| 68 | CAMK1D | 0.80906329 |
| 69 | MTOR | 0.80656621 |
| 70 | MAPK11 | 0.80640135 |
| 71 | TNK2 | 0.78956381 |
| 72 | ALK | 0.78395608 |
| 73 | PDPK1 | 0.77015689 |
| 74 | MAP3K9 | 0.76365193 |
| 75 | TYRO3 | 0.75952141 |
| 76 | STK38 | 0.75487402 |
| 77 | PDK1 | 0.75466229 |
| 78 | SGK3 | 0.75176844 |
| 79 | EPHB2 | 0.75021662 |
| 80 | WNK4 | 0.73172365 |
| 81 | MAP3K3 | 0.72328362 |
| 82 | FES | 0.72122984 |
| 83 | ZAP70 | 0.70707729 |
| 84 | IRAK2 | 0.70577687 |
| 85 | GRK6 | 0.67628816 |
| 86 | PTK2 | 0.66853566 |
| 87 | NTRK1 | 0.66661056 |
| 88 | WNK1 | 0.65863034 |
| 89 | PAK2 | 0.64849685 |
| 90 | CDK19 | 0.64187110 |
| 91 | CAMK4 | 0.64180069 |
| 92 | WNK3 | 0.63871465 |
| 93 | STK10 | 0.63064134 |
| 94 | KSR2 | 0.62805461 |
| 95 | CAMK1 | 0.61513927 |
| 96 | PAK6 | 0.61372811 |
| 97 | RPS6KA6 | 0.61187010 |
| 98 | CSF1R | 0.60880245 |
| 99 | DAPK3 | 0.60110210 |
| 100 | CSK | 0.59889390 |
| 101 | MOS | 0.59350949 |
| 102 | STK11 | 0.58681776 |
| 103 | BRAF | 0.56317154 |
| 104 | UHMK1 | 0.56021119 |
| 105 | IRAK4 | 0.55461154 |
| 106 | MAPK12 | 0.55369550 |
| 107 | CDK6 | 0.55155285 |
| 108 | CDC42BPA | 0.54721621 |
| 109 | MAP2K4 | 0.52367500 |
| 110 | ILK | 0.52223731 |
| 111 | NTRK3 | 0.52186098 |
| 112 | ITK | 0.50345068 |
| 113 | PAK4 | 0.50204560 |
| 114 | MAP2K2 | 0.49913054 |
| 115 | FGFR3 | 0.49391887 |
| 116 | MAP3K13 | 0.49038315 |
| 117 | HCK | 0.48444493 |
| 118 | FGFR2 | 0.47715826 |
| 119 | SIK3 | 0.47447411 |
| 120 | MAP3K2 | 0.46742761 |
| 121 | MAP2K6 | 0.46711761 |
| 122 | GSK3A | 0.46126193 |
| 123 | CSNK1A1L | 0.46001932 |
| 124 | RPS6KA2 | 0.45293831 |
| 125 | CDK4 | 0.44190788 |
| 126 | BLK | 0.44075930 |
| 127 | ABL2 | 0.42856638 |
| 128 | PDGFRB | 0.42763802 |
| 129 | TESK2 | 0.41484344 |
| 130 | IKBKE | 0.41259063 |
| 131 | MAPK7 | 0.39870492 |
| 132 | ERBB2 | 0.39514286 |
| 133 | CDK11A | 0.38938964 |
| 134 | CSNK1G1 | 0.38546952 |
| 135 | MAPK4 | 0.36383423 |
| 136 | MST1R | 0.35521166 |
| 137 | LIMK1 | 0.35459194 |
| 138 | MAP3K8 | 0.35160816 |
| 139 | MAP3K14 | 0.34699074 |
| 140 | PRKG2 | 0.34473534 |
| 141 | CDK15 | 0.34132693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.74227744 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.37836469 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.88781214 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69215954 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.66779232 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.27006127 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.26013322 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.09184813 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.04808561 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.01294228 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.98120385 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.79447601 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.76941943 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.72443537 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.61126794 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60410066 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.58892847 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.57297492 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55494995 |
| 20 | Lysine degradation_Homo sapiens_hsa00310 | 1.52079594 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.51622332 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.47087880 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37001340 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35290066 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33829442 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28844359 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.25039451 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.23507135 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21859673 |
| 30 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.21382028 |
| 31 | Insulin resistance_Homo sapiens_hsa04931 | 1.18757351 |
| 32 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.13096907 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.10510664 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.08702275 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05048591 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04033903 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01260703 |
| 38 | Focal adhesion_Homo sapiens_hsa04510 | 0.99892318 |
| 39 | Ribosome_Homo sapiens_hsa03010 | 0.97732775 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.96881612 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96390670 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.94758017 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93480579 |
| 44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92974018 |
| 45 | Thyroid cancer_Homo sapiens_hsa05216 | 0.90414728 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90323195 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 0.89558901 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 0.88976934 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88194904 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87987916 |
| 51 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87845626 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87210553 |
| 53 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86352192 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.86323677 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85989282 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84886373 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84632468 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84374422 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81335192 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81240122 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81098331 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80921782 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 0.79553478 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79202606 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.78947470 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78494434 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.78130335 |
| 68 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77520467 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77403969 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77206276 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77170003 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.77132054 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76565368 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76186075 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75599837 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.75522461 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74569436 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74189250 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73924311 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73689156 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73269101 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73180092 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.73092304 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72611314 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72269350 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72185379 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71847536 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.71269170 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70371280 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70043345 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68859944 |
| 92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.68244776 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68176267 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.67847699 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67614977 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66785622 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65958252 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.65669553 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65367192 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64854208 |
| 101 | Insulin secretion_Homo sapiens_hsa04911 | 0.64394863 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64357842 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63644332 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63174475 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.63013701 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.62563929 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.62472170 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61589617 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61559551 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61370667 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61367790 |
| 112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61211742 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61128341 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61104848 |
| 115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59710527 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58442955 |
| 117 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58039178 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56696287 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.55826929 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55823400 |
| 121 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54446528 |
| 122 | Gap junction_Homo sapiens_hsa04540 | 0.53008254 |
| 123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50984970 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50762829 |
| 125 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50642246 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50526609 |
| 127 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50512826 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50386749 |
| 129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49797075 |
| 130 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49624059 |
| 131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49594716 |
| 132 | Shigellosis_Homo sapiens_hsa05131 | 0.48726407 |
| 133 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45865133 |
| 134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45163972 |
| 135 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.43610184 |
| 136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43168973 |
| 137 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43110118 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43064263 |
| 139 | Amoebiasis_Homo sapiens_hsa05146 | 0.42928145 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41739436 |
| 141 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41701905 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40045895 |
| 143 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39583457 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.38931413 |
| 145 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38492080 |
| 146 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38117201 |
| 147 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38044127 |
| 148 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36340794 |
| 149 | Platelet activation_Homo sapiens_hsa04611 | 0.35228109 |
| 150 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35189870 |
| 151 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34656309 |
| 152 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34237185 |
| 153 | Renin secretion_Homo sapiens_hsa04924 | 0.34065708 |

